MAGNACHIP SEMICONDUCTOR Corp
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
MX$2.53+1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Interim Consolidated Financial Statements (Unaudited)
CONSOLIDATED BALANCE SHEETS (Unaudited)
| September 30,2026 | December 31,2025 | |
|---|---|---|
| (In thousands of U.S. dollars, except share data) | ||
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $86,911 | $103,756 |
| Accounts receivable, net | 24,870 | 26,022 |
| Inventories, net | 40,444 | 34,151 |
| Other receivables | 4,830 | 2,882 |
| Prepaid expenses | 4,723 | 5,062 |
| Hedge collateral (Note 8) | — | 1,200 |
| Other current assets (Note 18) | 7,500 | 3,782 |
| Total current assets | 169,278 | 176,855 |
| Property, plant and equipment, net | 103,381 | 100,204 |
| Operating lease right-of-use assets | 1,377 | 2,070 |
| Intangible assets, net | 460 | 454 |
| Long-term prepaid expenses, net | 564 | 584 |
| Deferred income taxes | 62,086 | 64,248 |
| Other non-current assets | 6,644 | 7,114 |
| Total assets | $343,790 | $351,529 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $19,513 | $20,848 |
| Other accounts payable | 4,402 | 11,444 |
| Accrued expenses (Note 7) | 7,066 | 6,929 |
| Accrued income taxes | 17 | 81 |
| Operating lease liabilities | 1,206 | 1,427 |
| Current portion of long-term borrowings (Note 11) | 29,998 | — |
| Other current liabilities | 1,682 | 2,681 |
| Total current liabilities | 63,884 | 43,410 |
| Long-term borrowings (Note 11) | 17,112 | 44,599 |
| Accrued severance benefits, net | 14,429 | 11,502 |
| Non-current operating lease liabilities | 212 | 690 |
| Other non-current liabilities | 2,737 | 3,078 |
| Total liabilities | 98,374 | 103,279 |
| Commitments and contingencies (Note 18) | ||
| Stockholders’ equity | ||
| Common stock, $0.01 par value, 150,000,000 shares authorized, 59,849,913 shares issued and 38,041,317 outstanding at September 30, 2026 and 58,027,696 shares issued and 36,219,100 outstanding at December 31, 2025 | 598 | 579 |
| Additional paid-in capital | 290,472 | 281,537 |
| Retained earnings | 192,847 | 214,852 |
| Treasury stock, 21,808,596 shares at September 30, 2026 and 21,808,596 shares at December 31, 2025, respectively | (229,910) | (229,910) |
| Accumulated other comprehensive loss | (8,591) | (18,808) |
| Total stockholders’ equity | 245,416 | 248,250 |
| Total liabilities and stockholders’ equity | $343,790 | $351,529 |
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| September 30,2026 | September 30,2025 | September 30,2026 | September 30,2025 | |
| (In thousands of U.S. dollars, except share data) | ||||
| Net sales | $43,978 | $45,946 | $134,890 | $138,290 |
| Cost of sales | 37,801 | 37,405 | 112,871 | 110,675 |
| Gross profit | 6,177 | 8,541 | 22,019 | 27,615 |
| Operating expenses: | ||||
| Selling, general and administrative expenses | 8,779 | 8,312 | 25,192 | 26,491 |
| Research and development expenses | 8,357 | 7,773 | 22,951 | 19,698 |
| Early termination and other charges | 1,921 | 3,994 | 3,902 | 4,840 |
| Total operating expenses | 19,057 | 20,079 | 52,045 | 51,029 |
| Operating loss | (12,880) | (11,538) | (30,026) | (23,414) |
| Interest income | 893 | 1,255 | 2,905 | 4,117 |
| Interest expense | (317) | (469) | (1,010) | (1,265) |
| Foreign currency gain (loss), net | 1,811 | (4,280) | 1,170 | 6,112 |
| Other income, net | 2,078 | 253 | 2,354 | 284 |
| Loss from continuing operations before income tax expense (benefit), net | (8,415) | (14,779) | (24,607) | (14,166) |
| Income tax expense (benefit), net | 4,871 | (4,170) | 977 | (8,709) |
| Loss from continuing operations | (13,286) | (10,609) | (25,584) | (5,457) |
| Income (Loss) from discontinued operations, net of tax | 743 | (2,481) | 3,579 | (16,188) |
| Net loss | $(12,543) | $(13,090) | $(22,005) | $(21,645) |
| Basic earnings (loss) per common share— | ||||
| Continuing operations | $(0.36) | $(0.29) | $(0.70) | $(0.15) |
| Discontinued operations | $0.02 | $(0.07) | $0.10 | $(0.45) |
| Total | $(0.34) | $(0.36) | $(0.60) | $(0.60) |
| Diluted earnings (loss) per common share— | ||||
| Continuing operations | $(0.36) | $(0.29) | $(0.70) | $(0.15) |
| Discontinued operations | $0.02 | $(0.07) | $0.10 | $(0.45) |
| Total | $(0.34) | $(0.36) | $(0.60) | $(0.60) |
| Weighted average number of shares— | ||||
| Basic | 36,649,278 | 35,934,406 | 36,504,776 | 36,298,491 |
| Diluted | 36,649,278 | 35,934,406 | 36,504,776 | 36,298,491 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| September 30,2026 | September 30,2025 | September 30,2026 | September 30,2025 | |
| (In thousands of U.S. dollars) | ||||
| Net loss | $(12,543) | $(13,090) | $(22,005) | $(21,645) |
| Other comprehensive income (loss) | ||||
| Foreign currency translation adjustments | 16,918 | (505) | 6,572 | 1,125 |
| Derivative adjustments | 7,283 | (1,022) | 3,645 | 1,335 |
| Total other comprehensive income (loss) | 24,201 | (1,527) | 10,217 | 2,460 |
| Total comprehensive income (loss) | $11,658 | $(14,617) | $(11,788) | $(19,185) |
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (Unaudited)
| (In thousands of U.S. dollars, · Common Stock · AdditionalPaid-In · Retained · Treasury · AccumulatedOtherComprehensive | |||||||
|---|---|---|---|---|---|---|---|
| except share data) | Shares | Amount | Capital | Earnings | Stock | Loss | Total |
| Three Months Ended September 30, 2026: | |||||||
| Balance at June 30, 2026 | 36,510,111 | $581 | $283,263 | $205,390 | $(229,910) | $(32,792) | $226,532 |
| Stock-based compensation | — | — | 2,366 | — | — | — | 2,366 |
| Issuance of common stock | 1,461,988 | 15 | 4,845 | — | — | — | 4,860 |
| Settlement of restricted stock units | 69,218 | 2 | (2) | — | — | — | — |
| Other comprehensive income, net | — | — | — | — | — | 24,201 | 24,201 |
| Net loss | — | — | — | (12,543) | — | — | (12,543) |
| Balance at September 30, 2026 | 38,041,317 | $598 | $290,472 | $192,847 | $(229,910) | $(8,591) | $245,416 |
| Three Months Ended September 30, 2025: | |||||||
| Balance at June 30, 2025 | 35,954,038 | $575 | $280,853 | $236,021 | $(229,381) | $(17,906) | $270,162 |
| Stock-based compensation | — | — | 123 | — | — | — | 123 |
| Settlement of restricted stock units | 92,981 | 1 | (1) | — | — | — | — |
| Acquisition of treasury stock | (98,597) | — | — | — | (319) | — | (319) |
| Other comprehensive loss, net | — | — | — | — | — | (1,527) | (1,527) |
| Net loss | — | — | — | (13,090) | — | — | (13,090) |
| Balance at September 30, 2025 | 35,948,422 | $576 | $280,975 | $222,931 | $(229,700) | $(19,433) | $255,349 |
| (In thousands of U.S. dollars, · Common Stock · AdditionalPaid-In · Retained · Treasury · AccumulatedOtherComprehensive | |||||||
|---|---|---|---|---|---|---|---|
| except share data) | Shares | Amount | Capital | Earnings | Stock | Loss | Total |
| Nine Months Ended September 30, 2026: | |||||||
| Balance at December 31, 2025 | 36,219,100 | $579 | $281,537 | $214,852 | $(229,910) | $(18,808) | $248,250 |
| Stock-based compensation | — | — | 4,028 | — | — | — | 4,028 |
| Issuance of common stock | 1,472,797 | 15 | 4,911 | — | — | — | 4,926 |
| Settlement of restricted stock units | 349,420 | 4 | (4) | — | — | — | — |
| Other comprehensive income, net | — | — | — | — | — | 10,217 | 10,217 |
| Net loss | — | — | — | (22,005) | — | — | (22,005) |
| Balance at September 30, 2026 | 38,041,317 | $598 | $290,472 | $192,847 | $(229,910) | $(8,591) | $245,416 |
| Nine Months Ended September 30, 2025: | |||||||
| Balance at December 31, 2024 | 36,912,118 | $574 | $279,423 | $244,576 | $(225,883) | $(21,893) | $276,797 |
| Stock-based compensation | — | — | 1,615 | — | — | — | 1,615 |
| Settlement of restricted stock units | 175,749 | 2 | (63) | — | — | — | (61) |
| Acquisition of treasury stock | (1,139,445) | — | — | — | (3,817) | — | (3,817) |
| Other comprehensive income, net | — | — | — | — | — | 2,460 | 2,460 |
| Net loss | — | — | — | (21,645) | — | — | (21,645) |
| Balance at September 30, 2025 | 35,948,422 | $576 | $280,975 | $222,931 | $(229,700) | $(19,433) | $255,349 |
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
| Nine Months Ended | ||
|---|---|---|
| September 30,2026 | September 30,2025 | |
| (In thousands of U.S. dollars) | ||
| Cash flows from operating activities | ||
| Net loss | $(22,005) | $(21,645) |
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Depreciation and amortization | 8,588 | 9,938 |
| Provision for severance benefits | 3,611 | 2,868 |
| Gain on foreign currency, net | (5,305) | (10,612) |
| Provision (reversal) for inventory reserves | (379) | 1,919 |
| Stock-based compensation | 4,028 | 1,615 |
| Impairment charges | — | 12,424 |
| Gain from disposal of investment securities | (2,146) | — |
| Deferred income taxes | 5,436 | (569) |
| Others, net | 153 | 220 |
| Changes in operating assets and liabilities | ||
| Accounts receivable, net | 2,036 | (7,610) |
| Inventories | (3,509) | (7,131) |
| Other receivables | (1,977) | (1,287) |
| Prepaid expenses | 1,704 | 5,325 |
| Other current assets | (3,211) | (3,247) |
| Accounts payable | (1,103) | 641 |
| Other accounts payable | (6,220) | (6,803) |
| Accrued expenses | (177) | 1,925 |
| Accrued income taxes | (63) | (16) |
| Other current liabilities | 593 | (323) |
| Other non-current liabilities | 423 | (48) |
| Payment of severance benefits | (884) | (10,669) |
| Others, net | (745) | 3,446 |
| Net cash used in operating activities | (21,152) | (29,639) |
| Cash flows from investing activities | ||
| Proceeds from settlement of hedge collateral | 9,669 | 2,237 |
| Payment of hedge collateral | (8,493) | — |
| Proceeds from disposal of property, plant and equipment | 49 | 554 |
| Purchase of property, plant and equipment | (7,566) | (19,739) |
| Payment for intellectual property registration | (120) | (182) |
| Proceeds from sale of investment securities | 2,157 | — |
| Collection of guarantee deposits | 2,030 | 4,274 |
| Payment of guarantee deposits | (442) | (355) |
| Others, net | — | 180 |
| Net cash used in investing activities | (2,716) | (13,031) |
| Cash flows from financing activities | ||
| Proceeds from long-term borrowings | — | 10,611 |
| Proceeds from issuance of common stock | 4,925 | — |
| Acquisition of treasury stock | (201) | (4,340) |
| Repayment of financing related to water treatment facility arrangement | (330) | (341) |
| Repayment of principal portion of finance lease liabilities | (99) | (121) |
| Net cash provided by financing activities | 4,295 | 5,809 |
| Effect of exchange rates on cash and cash equivalents | 2,728 | 6,256 |
| Net decrease in cash and cash equivalents | (16,845) | (30,605) |
| Cash and cash equivalents | ||
| Cash and cash equivalents at beginning of period | 103,756 | 138,610 |
| Cash and cash equivalents at end of period | $86,911 | $108,005 |
| Supplemental cash flow information | ||
| Cash paid for interest on borrowings | $1,170 | $927 |
| Cash refunded for income taxes | $(718) | $(1,043) |
| Non-cash investing activities | ||
| Property, plant and equipment additions in other accounts payable | $947 | $2,220 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.